Show simple item record

Authordc.contributor.authorQuezada Lagos, Arnoldo 
Authordc.contributor.authorBaron-Papillon, Florence es_CL
Authordc.contributor.authorCoudeville, Laurent es_CL
Authordc.contributor.authorMaggi Campos, Leonardo es_CL
Admission datedc.date.accessioned2010-01-13T21:03:27Z
Available datedc.date.available2010-01-13T21:03:27Z
Publication datedc.date.issued2008-05
Cita de ítemdc.identifier.citationREVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, Volume: 23, Issue: 5, Pages: 303-312, 2008en_US
Identifierdc.identifier.issn1020-4989
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/128164
Abstractdc.description.abstractObjective. To evaluate the healthcare and economic impact of routine hepatitis A vaccination of toddlers in Chile. Methods. We used a dynamic model of hepatitis A infection to evaluate the impact of a twodose vaccination program, administered at ages 12 and 18 months. The model incorporated the changing epidemiology of hepatitis A in Chile and the development of vaccine-induced herd immunity. Our analysis was conducted from the public payer perspective, and an estimation of the societal perspective was performed. Costs are expressed in 2005 U.S. dollars. Results. Vaccination of toddlers rapidly reduced the healthcare burden of hepatitis A. In the base case (95% vaccination coverage, 100-year time horizon, 1% annual decrease in force of infection), the average number of infections fell by 76.6% annually, and associated deaths fell by 59.7%. Even at 50% coverage, the program reduced infection rates substantially. Routine vaccination of toddlers had economic as well as health benefits, saving $4 984 per life-year gained (base case scenario). The program became cost saving after 6 years, and its overall costeffectiveness per life-year gained was largely unaffected by changes in disease-related costs, herd immunity, coverage rate, and annual decrease in force of infection. Conclusions. Routine vaccination of toddlers will reduce the rates of symptomatic hepatitis A and associated mortality. The two-dose schedule evaluated here will be less expensive than disease-related costs in the absence of vaccination from the sixth year of its implementation. These findings support the establishment of a routine vaccination program for toddlers in Chile.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherPAN AMER HEALTH ORGANIZATIONen_US
Keywordsdc.subjectVaccinationen_US
Títulodc.titleUniversal vaccination of children against hepatitis A in Chile: a cost-effectiveness studyen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record